Hepatitis C: An unsuspected drug target.
Murray
Catherine L
CL
Rice
Charles M
CM
D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D024882:Drug Resistance, Viral / Q000235:genetics; D016174:Hepacivirus / Q000187:drug effects*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D009154:Mutation / Q000235:genetics; D017361:Viral Nonstructural Proteins / Q000235:genetics / Q000378:metabolism; D014779:Virus Replication / Q000187:drug effects; D012324:RNA-Dependent RNA Polymerase
D000998:Antiviral Agents; D017361:Viral Nonstructural Proteins; C087036:NS-5 protein, hepatitis C virus; D012324:RNA-Dependent RNA Polymerase
Nature. 2005 May 19;435(7040):374-9
15902263
Nat Genet. 2009 Oct;41(10):1100-4
19749758
Nature. 2009 Sep 17;461(7262):399-401
19684573
Nature. 2010 May 6;465(7294):96-100
20410884
Nature. 2005 Aug 18;436(7053):953-60
16107835
J Virol. 2010 Jan;84(1):482-91
19812153
Nat Genet. 2009 Oct;41(10):1105-9
19749757
Curr Opin Pharmacol. 2008 Oct;8(5):522-31
18835365
PLoS Pathog. 2008 Mar 28;4(3):e1000035
18369481
PLoS Pathog. 2008 Mar 21;4(3):e1000032
18369478
J Virol. 2009 May;83(9):4395-403
19244328